In the medical device industry, everything we do is about improving patient care – it’s the purpose behind all technological advancements. Through innovation in robotic-assisted surgery, Nami’s technology has the potential to truly transform the standard of patient care – and patient outcomes – around the world. Here’s how:

The technology
The standard of care for many surgeries is the ultrasonic scalpel – an instrument that, when first introduced, significantly improved the efficacy of surgical procedures. Separately, robotic-assisted surgery has emerged as a major advancement, offering greater precision during operations.

The problem?
These two innovations have remained incompatible. Ultrasonic scalpels are typically too large and inflexible to integrate with wristed robotic-assisted surgical equipment – until now.

Nami’s pioneering technology is a miniaturised ultrasonic scalpel designed specifically for use in robotic-assisted surgery. By enabling the integration of ultrasonic energy with robotic precision, surgeons can benefit from improved dexterity, enhanced visualisation, and reduced invasiveness – all with a single tool that cuts and cauterises simultaneously.

Transforming patient outcomes
This existing incompatibility has created a significant unmet clinical need, limiting millions of procedures worldwide – and, in turn, impacting patient outcomes. Nami’s technology can help improve patient care in the following ways:

• Faster recovery – Nami’s miniaturised design enables more precise navigation through tissue planes, reducing trauma and requiring smaller incisions – which can lead to quicker recovery times.
• Minimised unintended tissue damage – Enhanced surgical precision limits micro-damage and reduces the risk of harming nearby tissue. This is especially crucial in delicate procedures near critical structures where the stakes are higher.
• Broader surgical applications – As surgery continues to evolve, innovations like Nami’s pave the way for wider applications. This means more patients, with a broader range of surgical needs, could benefit from advanced, minimally invasive procedures.

Co-founder of Nami, Dr Rebecca Cleary, commented:
“Our core design principle is technology built with patients in mind – it drives everything we do. Our technology has the potential to revolutionise robotic-assisted surgery, and we’re developing a pipeline of innovations that build on this foundation. Ultimately, we’re all working toward the same goal – better patient care and outcomes.”

You can learn more about Nami’s transformative technology here or explore the latest news and updates.